Literature DB >> 26374454

What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?

Gopesh K Modi1, Rajiv Agarwal2,3.   

Abstract

To maximize the risk benefit ratio of blood pressure control in people with chronic kidney diseases (CKD), a number of guidelines provide recommendations on optimal blood pressure (BP) targets in CKD. This review examines these guidelines, their supporting evidence base, and generalizability and limitations of current standards of care. Over the years, the BP targets are liberalized. They now focus on the usual BP target of <140/90 mmHg. In the elderly, where guidelines call for a target of <150/90 mmHg in the general population, the recommendations provide room for the clinician to tailor therapy. Among those with albuminuria of >300 mg/g creatinine, low-quality evidence suggests targeting BP to <130/90 mmHg. Individualization of BP lowering is a key based on comorbid conditions, response to treatment, and level of kidney function. Consideration of out of clinic BP monitoring either implemented by home BP recordings or ambulatory BP measurements may enhance BP control.

Entities:  

Keywords:  Ambulatory BP monitoring; Chronic kidney disease; Hypertension; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26374454     DOI: 10.1007/s11886-015-0650-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  26 in total

1.  Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease.

Authors:  Daniel E Weiner; Hocine Tighiouart; Andrew S Levey; Essam Elsayed; John L Griffith; Deeb N Salem; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2007-02-14       Impact factor: 10.121

2.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Walter T Ambrosius; Kaycee M Sink; Capri G Foy; Dan R Berlowitz; Alfred K Cheung; William C Cushman; Lawrence J Fine; David C Goff; Karen C Johnson; Anthony A Killeen; Cora E Lewis; Suzanne Oparil; David M Reboussin; Michael V Rocco; Joni K Snyder; Jeff D Williamson; Jackson T Wright; Paul K Whelton
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

3.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

Review 5.  High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs.

Authors:  Samantha Bromfield; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

7.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

Review 8.  Pharmacotherapy for hypertension in the elderly.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

9.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

Review 10.  Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

Authors:  T Ninomiya; V Perkovic; F Turnbull; B Neal; F Barzi; A Cass; C Baigent; J Chalmers; N Li; M Woodward; S MacMahon
Journal:  BMJ       Date:  2013-10-03
View more
  4 in total

1.  Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics.

Authors:  Roberto Minutolo; Luca De Nicola; Ciro Gallo; Paolo Chiodini; Michele Provenzano; Giuseppe Conte; Carlo Garofalo; Silvio Borrelli
Journal:  J Nephrol       Date:  2019-01-23       Impact factor: 3.902

2.  Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses.

Authors:  Panagiotis I Georgianos; Pantelis E Zebekakis; Vassilios Liakopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

3.  Hypertension in Chronic Kidney Disease (CKD): Diagnosis, Classification, and Therapeutic Targets.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Am J Hypertens       Date:  2021-04-20       Impact factor: 2.689

4.  Physician perceptions of blood pressure control in patients with chronic kidney disease and target blood pressure achievement rate.

Authors:  Ran-Hui Cha; Hajeong Lee; Jung Pyo Lee; Young Rim Song; Sung Gyun Kim; Yon Su Kim
Journal:  Kidney Res Clin Pract       Date:  2017-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.